Drug intelligence / Profile preview

PrimaGen Advanced Allograft

Development stage
Unknown
Lead developer
Zimmer Biomet
Modality
Cell Therapies
Administration
Implant
01

Overview

PrimaGen Advanced Allograft is an allogeneic bone graft substitute developed by Zimmer Biomet and currently part of the ZimVie spine portfolio. It is a biologic product composed of a combination of cancellous bone and demineralized cortical bone fibers, enriched with viable donor cells including mesenchymal stem cells (MSCs), osteoprogenitor cells, and pre-osteoblasts. The product is a fresh frozen allograft that is cryopreserved using proprietary methods to maintain the endogenous components of native bone. It provides the three essential elements for bone healing: osteoconductivity (scaffold), osteoinductivity (growth factors), and osteogenicity (viable cells). PrimaGen Advanced is indicated for the repair, replacement, or reconstruction of musculoskeletal defects, serving as an alternative to autografts to avoid donor site morbidity.

Brand names
PrimaGen Advanced Allograft
Other names
PrimaGen Advanced

Beyond the preview

Go deeper on PrimaGen Advanced Allograft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrimaGen Advanced Allograft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call